mouse and human origin using Western blotting. This ALK (F-12) antibody is also used by other laboratories for Western blot (www. scbt.com/scbt/product/alk-antibody-f-12/). The molecular weight of normal human and mouse ALK is 176 and 175 kDa, respectively. Consistent with antibody datasheets, we saw a band around 170 to 190 kDa in human and mouse macrophages or monocytes using ALK (F-12) antibody (1) . We knocked down ALK by specific short hairpin RNA-ALK and showed reduced expression using ALK (F-12) antibody (1 of ALK (F-12) antibody (Fig. 1A) . Functionally, ALK depletion blocked 3′3′-cGAMP (cyclic guanosine monophosphate-adenosine monophosphate) or c-di-AMP-induced interferon- (IFN-) mRNA expression ( Fig. 1B) and release ( Fig. 1C ) in peritoneal macrophages from septic ALK −/− mice, also supporting our previous conclusion that ALK promotes STING activation in macrophages.
In contrast to our results showing the molecular weight of ALK at 175 to 175 kDa, Blasco et al. (2) claimed that 220-to 230-kDa full length is the normal form of ALK. This claim contradicts their previous observation that 170 to 190 kDa corresponds to full-length ALK in lung cancer cells (4) . Another concern was the use of the Raji cell line as a negative control of ALK expression by Blasco et al. (2) . In contrast, ALK (F-12) antibody datasheets indicate that the Raji cell line is a positive control of ALK expression. Thus, the claim of 220-to 230-kDa full length (2) could be nonspecific for other forms of ALK. ALK is cleaved by caspase in apoptosis (5). Blasco et al. Blasco et al. (2) claimed that "immunohistochemistry failed to detect ALK expression in normal macrophages surrounding ALK-rearranged NSCLC and ALCL." ALK-rearranged non-small cell lung cancer (NSCLC) patients often present with infection. Macrophages are among the most abundant normal cells in the tumor microenvironment. Tumor-associated macrophages are different from normal macrophages in activation and function (6) . Unfortunately, Blasco et al. (2) did not stain for macrophage markers. Thus, it is difficult to distinguish macrophages from other cells, such as megakaryocytes, in the tumor microenvironment. F4/80 (also termed EMR1 in humans) is a macrophage marker. We observed a strong colocalization signal between ALK and F4/80 in lung from septic mice (Fig. 1D) and lung tumor from a patient with NSCLC (Fig. 1E) , indicating that ALK is expressed by macrophages.
The third major concern raised by Blasco et al. (2) was the offtarget effects of ALK inhibition. The use of ALK inhibitor concentration in cell culture is usually higher than in a cell-free system. In addition to using ALK inhibitors, we also observed that genetic knockdown or deletion of ALK blocks cyclic dinucleotide-induced STING activation, indicating that ALK plays a role in the regulation of STING activation in macrophages (1). We also observed that ALK inhibitor, ALK knockdown, and STING knockdown have overlapping and distinct immune functions in cytokine and chemokine release in macrophages (1).
Our bioinformatics, Western blot, real-time polymerase chain reaction, and image analysis confirmed ALK expression in human and mouse monocytes and macrophages. We observed that pharmacologic or genetic inhibition of ALK limited STING activation in monocytes and macrophages (1) . Moreover, animal studies showed that Alk −/− mice are more resistant to polymicrobial sepsis ( Fig. 2A) .Biochemical measurement of tissue enzymes also revealed protective effects of ALK depletion against dysfunction of the heart (creatine kinase), pancreas (amylase), kidney (blood urea nitrogen), and liver (alanine aminotransferase) (Fig. 2B) .These findings support a role for ALK in lethal infection. Notably, other independent groups also observed that ALK signaling affects macrophages. For example, a recent drug screen study identified ALK as a top activator of STING in macrophages and monocytes (7) . This study found that 18 different ALK inhibitors could block STING activation in response to 2′3′-cGAMP in macrophages and monocytes (7) . ALK in tumor-associated macrophages promoted tumor metastasis through sustaining inflammation (8) . ALK also plays a role in promoting NALP3 (NLR family pyrin domain containing 3) inflammasome activation and pyroptosis in macrophages (9) . The conclusions from these studies agree with our conclusion that ALK is a regulator of inflammation and innate immunity in macrophages and monocytes. In parallel, indicated serum enzyme activity (day 3) was assayed (n = 5 mice per group; *P < 0.05). CK, creatinine kinase; AMYL, amylase; BUN; blood urea nitrogen; ALT, alanine aminotransferase.
